Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER.
Ziemssen T, Posevitz-Fejfár A, Chudecka A, Cepek L, Reifschneider G, Grothe C, Richter J, Wagner T, Müller B, Penner IK. Ziemssen T, et al. Among authors: chudecka a. Mult Scler Relat Disord. 2024 Oct;90:105812. doi: 10.1016/j.msard.2024.105812. Epub 2024 Aug 10. Mult Scler Relat Disord. 2024. PMID: 39151238 Free article.
IMPAACT: IMproving the PArticipAtion of older people in policy decision-making on common health CondiTions - a study protocol.
Ambagtsheer RC, Hurley CJ, Lawless M, Braunack-Mayer A, Visvanathan R, Beilby J, Stewart S, Cornell V, Leach MJ, Taylor D, Thompson M, Dent E, Whiteway L, Archibald M, O'Rourke HM, Williams K, Chudecka A. Ambagtsheer RC, et al. Among authors: chudecka a. BMJ Open. 2024 Jan 12;14(1):e075501. doi: 10.1136/bmjopen-2023-075501. BMJ Open. 2024. PMID: 38216190 Free PMC article.
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy.
Wiendl H, Schmierer K, Hodgkinson S, Derfuss T, Chan A, Sellebjerg F, Achiron A, Montalban X, Prat A, De Stefano N, Barkhof F, Leocani L, Vermersch P, Chudecka A, Mwape C, Holmberg KH, Boschert U, Roy S; MAGNIFY-MS Study Group. Wiendl H, et al. Among authors: chudecka a. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 21;10(1):e200048. doi: 10.1212/NXI.0000000000200048. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36411081 Free PMC article.
Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis.
Schmierer K, Wiendl H, Oreja-Guevara C, Centonze D, Chudecka A, Roy S, Boschert U. Schmierer K, et al. Among authors: chudecka a. Mult Scler. 2022 Nov;28(13):2151-2153. doi: 10.1177/13524585221099413. Epub 2022 Jun 7. Mult Scler. 2022. PMID: 35672923 Free PMC article. No abstract available.